Employee Benefit Plans (Tables)

6 Months Ended

Jun. 30, 2023

Retirement Benefits [Abstract]

Schedule of Stock Option Activity under the Plans

Stock option activity for the six months ended June 30, 2023 was as follows:

	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value
Balance—December 31, 2022	18,153,195	$	6.07	5.41	$	120,289
Granted	454,626	14.72
Exercised	(3,259,812)	4.33
Canceled	(473,801)	10.23
Balance—June 30, 2023	14,874,208	$	6.58	5.34	$	108,844
Options vested	11,720,796	$	4.83	4.79	$	100,517

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

RSU activity for the six months ended June 30, 2023 was as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value		Aggregate Intrinsic Value
Unvested balance—December 31, 2022	22,773,053	$	17.75	$	269,779
Granted	5,840,206	11.14
Vested	(4,414,108)	19.00
Forfeited	(1,840,721)	21.60
Unvested balance—June 30, 2023	22,358,430	$	15.46	$	291,107

Summary of Stock-Based Compensation Expense in the Consolidated Statements of Operations

Stock-based compensation expense is classified in the Condensed Consolidated Statements of Operations (Unaudited) as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cost of revenue	$	914	$	812	$	1,791	$	1,389
Research and development	13,303		12,619		26,768		22,362
Sales and marketing	7,499		8,048		15,856		14,322
General and administrative	7,609		6,026		15,240		11,410
Restructuring related charges	(17)		—		$	(5,605)	—
Total	$	29,308	$	27,505	$	54,050	$	49,483

Summary of Shares of Common Stock Reserved for Future Issuance

The following table presents total shares of our common stock reserved for future issuance:

	June 30, 2023	December 31, 2022
Stock options outstanding	14,874,208	18,153,195
RSUs outstanding	22,358,430	22,773,053
Shares available for future grants	15,200,818	8,819,998
Total shares of common stock reserved	52,433,456	49,746,246